Suprachoroidal Space Injection Technique: Expert Panel Guidance

Author:

Wykoff Charles C.1ORCID,Avery Robert L.2,Barakat Mark R.3,Boyer David S.4,Brown David M.1,Brucker Alexander J.5,Cunningham Emmett T.6,Heier Jeffrey S.7,Holekamp Nancy M.8,Kaiser Peter K.9,Khanani Arshad M.10,Kim Judy E.11,Demirci Hakan12,Regillo Carl D.13,Yiu Glenn14,Ciulla Thomas A.15

Affiliation:

1. Retinal Consultants of Texas, Houston, TX

2. California Retina Consultants, Santa Barbara, CA

3. Retinal Consultants of Arizona, Phoenix, AZ; University of Arizona College of Medicine – Phoenix, Phoenix, AZ

4. Retina-Vitreous Associates Medical Group, Los Angeles, CA

5. University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

6. Department of Ophthalmology, California Pacific Medical Center, San Francisco, CA; The Francis I Proctor Foundation, UCSF School of Medicine, San Francisco, CA; Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA; West Coast Retina Medical Group, San Francisco, CA

7. Ophthalmic Consultants of Boston, Boston, MA

8. Pepose Vision Institute, St. Louis, MO; Roche Pharmaceuticals, Basel, CH

9. Cole Eye Institute, Cleveland, OH

10. Sierra Eye Associates, Reno, NV; University of Nevada, Reno School of Medicine, Reno, NV

11. Medical College of Wisconsin, Milwaukee, WI

12. Kellogg Eye Center, University of Michigan, Ann Arbor, MI

13. Mid Atlantic Retina, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA

14. University of California, Davis Health, Sacramento, CA

15. Chief Medical Advisor and Chair of Scientific Advisory Board, Clearside Biomedical, Alpharetta, GA

Abstract

Purpose: To develop professional guidelines for best practices for suprachoroidal space (SCS) injection, an innovative technique for retinal therapeutic delivery, based on current published evidence and clinical experience. Methods: A panel of expert ophthalmologists reviewed current published evidence and clinical experience during a live working group meeting to define points of consensus and key clinical considerations to inform the development of guidelines for in-office SCS injection. Results: Core consensus guidelines for in-office SCS injection were reached and reported by the expert panel. Current clinical evidence and physician experience supported SCS injection as a safe and effective method for delivering retinal and choroidal therapeutics. The panel established consensus on the rationale for SCS injection, including potential benefits relative to other intraocular delivery methods, and current best practices in patient preparation, pre- and peri-injection management, SCS-specific injection techniques, and post-injection management and follow-up. Conclusion: These expert panel guidelines may support and promote standardization of SCS injection technique, with the goal of optimizing patient safety and outcomes. Some aspects of the procedure may reasonably be modified based on clinical setting and physician judgement, as well as areas requiring additional study.

Funder

Clearside Biomedical, Alpharetta, GA

Bausch + Lomb, Bridgewater, NJ

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3